Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp. Warrant

0.0026
-0.0002-7.14%
Volume:23.06K
Turnover:56.83
Market Cap:4.56K
PE:0.00
High:0.0029
Open:0.0028
Low:0.0021
Close:0.0028
52wk High:0.2500
52wk Low:0.0017
Shares:1.76M
Float Shares:1.76M
Volume Ratio:0.57
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-53.2836
ROE:-444.07%
ROA:-161.64%
PB:0.00
PE(LYR):- -

Loading ...

Company Profile

Company Name:
BriaCell Therapeutics Corp. Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.